Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues

Despite the fact that COVID-19 vaccines are already available on the market, there have not been any effective FDA-approved drugs to treat this disease. There are several already known drugs that through drug repositioning have shown an inhibitory activity against SARS-CoV-2 RNA-dependent RNA polyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Daikopoulou, Vasiliki, Apostolou, Panagiotis, Mourati, Sofia, Vlachou, Ioanna, Gougousi, Maria, Papasotiriou, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201013/
https://www.ncbi.nlm.nih.gov/pubmed/34200204
http://dx.doi.org/10.3390/molecules26113461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201013/
https://www.ncbi.nlm.nih.gov/pubmed/34200204
http://dx.doi.org/10.3390/molecules26113461

Ejemplares similares